Here are four things to know:
1. The growth in the market is driven by the increasing number of minimally invasive surgeries, the rising prevalence of colorectal cancer, the increasing number of laparoscopic bariatric procedures and laparoscopy technological advancements.
2. Medical laparoscopic robots held the largest share of the global laparoscopic instrument market in 2020.
3. The bariatric surgery segment of laparoscopic devices is expected to grow at the highest rate between 2021 and 2026.
4. In terms of end-user segments in the laparoscopic device market, ASCs are projected to see the highest compound annual growth rate between 2021 and 2026, outpacing hospitals.
More articles on gastroenterology:
4 factors that will make or break a gastroenterology practice in the next 2 years
Colorectal cancer deaths estimated in 2021: A state-by-state breakdown
Hospital sues gastroenterologists attempting to exit contracts: 5 details
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
